Tirzepatide: A dual GLP-1 and GIP receptor agonist that enhances insulin secretion, reduces hunger, and improves metabolic function, marketed under brand names like Mounjaro and Zepbound
Int Immunopharmacol 137:112489
[4] [5] Common adverse effects include nausea, vomiting, diarrhoea, constipation, and abdominal pain, particularly during the initial titration phase
A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19
Its safety and effectiveness in this younger age group have not been studied, so it is only prescribed for adults with type 2 diabetes
It has also been suggested that IF could benefit healthy people lose weight (9), even cyclists and men who practice resistance training (9, 16)